Open AccessPost-COVID Chronic Fatigue Syndrome: New Challenge Ahead
Author(s) -
Adwitiya Ray,
Neharika Saini
Publication year - 2021
Publication title -
international journal of science and healthcare research
Language(s) - English
Resource type - Journals
ISSN - 2455-7587
DOI - 10.52403/ijshr.20210776
Subject(s) - myalgia , chronic fatigue syndrome , medicine , malaise , encephalomyelitis , chronic fatigue , anxiety , coronavirus , vertigo , covid-19 , disease , immunology , physical therapy , infectious disease (medical specialty) , psychiatry , multiple sclerosis , surgery
Coronavirus disease 2019 (COVID-19) is a viral infection that causes various respiratory, gastrointestinal, and vascular symptoms. The acute illness phase lasts for about 2-3 weeks. However, there is increasing evidence that a percentage of COVID-19 patients continue to experience long-lasting symptoms characterized by fatigue, dyspnea, myalgia, exercise intolerance, and sleep disturbances, difficulty concentrating, anxiety, fever, headache, malaise, and vertigo. Similar symptoms are reported by patients who having myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS). ME/CFS pathology is not known: it is thought to be multifactorial, resulting from the dysregulation of multiple systems in response to a particular trigger. There is a resemblance between post-acute COVID-19 symptoms and ME/CFS. However, at present, there is inadequate evidence to establish COVID-19 as an infectious trigger for ME/CFS. Further research is required to determine the natural history of this condition, as well as to define risk factors, prevalence, and possible interventional strategies.Keywords: chronic fatigue syndrome, COVID-19, human coronavirus, myalgic encephalomyelitis, post-infectious fatigue, review.